Nov 13, 2019
News & Events
Press Releases
Oct 28, 2019
Salarius Pharmaceuticals and Aspire Capital Announce a $10.9M Common Stock Purchase Agreement
Initial Purchase of $1 Million of Salarius Shares Completed, Aspire Capital to Purchase Additional Salarius Common Stock over a 30-Month Span Extending into 2022 HOUSTON,...
Oct 8, 2019
Salarius Pharmaceuticals Adds Memorial Sloan Kettering Cancer Center and Nationwide Children’s Hospital as Clinical Sites for Phase 1/2 Trial of Seclidemstat in Ewing Sarcoma
Salarius Targeting Key Safety and Efficacy Data Milestones in 2020 HOUSTON, Oct. 8, 2019 -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting...
Sep 13, 2019
Salarius Pharmaceuticals Announces Senior Leadership Changes
Salarius Pharmaceuticals Announces Senior Leadership Changes Scott Jordan Appointed Chief Business Officer; Mark Rosenblum, Appointed Interim Chief Financial Officer HOUSTON, Sept. 13, 2019 -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX),...
Events
Oppenheimer Oncology Summit: The Evolving Strategies in Targeted Drug Development
The Microcap Rodeo
SALARIUS PHARMACEUTICALS, INC. RINGS THE NASDAQ STOCK MARKET OPENING BELL
Montauk Emerging Life Sciences Summit
In the News
SNN Network